Bank Of Nova Scotia Elanco Animal Health Inc Transaction History

Bank Of Nova Scotia

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$8.6 - $14.94 $2.31 Million - $4.02 Million	268,760 New	268,760 $4 Million
Q4 2022 Feb 09, 2023	SELL	$11.49 - $13.65 $7.98 Million - $9.48 Million	-694,310 Reduced 46.68%	792,913 $9.69 Million
Q3 2022 Nov 10, 2022	SELL	$12.41 - $32.42 $3.37 Million - $8.82 Million	-271,911 Reduced 15.46%	1,487,223 $18.5 Million
Q2 2022 Aug 08, 2022	BUY	$19.63 - $26.62 $34.5 Million - $46.8 Million	1,759,134 New	1,759,134 $34.5 Million
Q2 2022 Aug 05, 2022	SELL	$19.63 - $26.62 $34.5 Million - $46.7 Million	-1,755,464 Closed	0 $0
Q1 2022 May 09, 2022	SELL	$24.65 - $29.0 $12.3 Million - $14.5 Million	-499,692 Reduced 22.16%	1,755,464 $45.8 Million
Q4 2021 Feb 11, 2022	BUY	$27.74 - $34.09 $54.7 Million - $67.3 Million	1,973,044 Added 699.38%	2,255,156 $64 Million
Q3 2021 Nov 12, 2021	BUY	$29.2 - $36.72 $61,670 - $77,552	2,112 Added 0.75%	282,112 $9 Million
Q2 2021 Aug 12, 2021	BUY	$28.76 - $35.98 $8.05 Million - $10.1 Million	280,000 New	280,000 $9.71 Million

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Bank Of Nova Scotia, based on Form 13F filings with the SEC.

Stay updated on Bank Of Nova Scotia with notifications on news.